AI-First Scalable Molecule Design

Leveraging planet-scale data and AI to design better molecules, without the wait.

Our Platform

Drug design is a multi-objective problem currently being slowly solved one variable at a time. It's a major contributor to the >$1B price tag and the decade long process of drug development

We're developing a platform to deliver fast, multi-property molecule design capabilities to drug developers. We combine frontier molecule representation learning with the largest datasets to create a first-of-its-kind molecule design engine. Our goal is to accelerate the process by which the safe and effective therapeutics are made.

Our Team

Egbert Castro
CEO

Kevin Givechian
CSO

Xuefei Gao
COO

Our Mission


We approach drug design with a unwavering belief that patients deserve the safest, most effective therapeutics possible.


  • contact@ascentbio.xyz

  • www.ascentbio.xyz

11278 Los Alamitos Blvd.
Unit #896
Los Alamitos, CA 90720

© Ascent Bio 2024